Online supplements business Heights has crowdfunded over £2m as it bids to become a key player in the brain and gut health market.
The DTC business said its annual recurring revenue was £11m based on August sales, and it grew sales 30% from May to August.
The raise valued the company at £33.2m. Heights declined to comment.
The latest funds will be spent on expanding into Europe, launching new products, and advancing scientific research through clinical trials, its crowdfunding page said.
Heights was co-founded by Joel Freeman and Dan Murray-Serter in 2020. It sells three products for between £20 and £40 each for a month’s supply.
“We’ve absolutely loved building this company with our crowd – we have over 1,000 investors including many of our customers – but in the last two years we’ve exploded, and have many more customers (and friends) we want to invite to join the ride,” wrote Freeman on LinkedIn this month.
While over two thirds of British consumers use supplements, the market took a hit through the cost of living crisis, with 40% of users saying financial concerns prompted them to cut back, according to research by Mintel.
But high inflation drove growth in the category, with value sales up 25% to £568m from 2018 to 2023, said Mintel. It expects a further 10% growth between 2023 and 2028.
No comments yet